news Targeting drug resistance in HER2-positive breast cancer models Researchers discovered that HER2-positive breast cancer drugs must target both… 30 May 2024 | By Drug Target Review Researchers discovered that HER2-positive breast cancer drugs must target both HER2 and EGFR receptors to eradicate disease.